Eton Pharmaceuticals
etonpharma.com
Prescription Drugs
Health Care
Rare Disease Therapeutics
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$27.6M
2 rounds on record
Latest round
$7.5M
Venture round · Mar 2020 · 6 yr ago
Revenue
$1M
2019 · SEC Form D 0001493152-20-006039
Backers
1
Runway Growth Capital
The money's age
Long since its last round
79 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 27, 2025
Certified Eton Pharmaceuticals Announces FDA Approval and Upcoming Launch of KHINDIVI, the First and Only FDA-Approved Hydrocortisone Oral Solution for Pediatr… · Nasdaq
Mar 26, 2020
Raised a round Venture round $7.5M · SEC Form D
Jun 19, 2017
Raised a round Venture round $20.1M · SEC Form D
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2020 | $7.5M | — | SEC Form D |
| Venture round | Jun 2017 | $20.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Eton Pharmaceuticals, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Sean BrynjelsenExecutive Officer, DirectorSEC Form D
William TroutmanExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Explore the Kyntra Bio site to learn about our oncology and rare disease therapies, pipeline highlights, clinical trials, culture, and…
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
SynaptixBio is a rare disease biotech pioneering ground-breaking development for treatment of severe leukodystrophies which affect the…
Sidewinder Therapeutics is pioneering the next generation of large molecule precision therapeutics. We aim to deliver new life-saving…
Celestial Therapeutics is developing novel therapies based on innovative and groundbreaking science to treat, prevent and cure infectious…
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Runway Growth CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO (miltefosine) Capsules
Eton Pharmaceuticals now holds exclusive commercialization rights for IMPAVIDO in the United StatesEton has integrated full Eton Cares patient su...
Read more
Report
Eton Pharmaceuticals Announces Commercial Launch of IMPAVIDO Capsules with Enhanced Patient Support
Read more
Report
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO (miltefosine) Capsules
Eton Pharmaceuticals now holds exclusive commercialization rights for IMPAVIDO in the United StatesEton has integrated full Eton Cares patient support, including $0 co-pay for eligible commercially insured patients and expanded patient assistance programs
Read more
Report
Eton Pharmaceuticals stock gains 6.98 percent after Q2 results
Eton Pharmaceuticals stock reported USD 37.59 million in second quarter revenue against USD 27.11 million consensus. The company also raised guidance on August 13, 2026.
Read more
Report
Why Eton Pharmaceuticals Is Top of the Class Today
Eton's cure for an expensive valuation: a 99% sales growth rate.
Read more
Report
Eton Pharmaceuticals forecasts 2026 revenue to exceed $145M while targeting adjusted EBITDA margin above 35%
Read more
Report
Top Rapid Cashout Gambling Platforms in Australia
List of Sections Ultra-Quick Withdrawals: What Australian Users Should Know to Know The Way Player Confirmation Influences Your Personal Withdrawal Schedule Banking Solutions That Will Offer Instant Results Understanding Processing Durations and Platform
Read more
Report
Report
Eton Pharmaceuticals Announces FDA Approval and Upcoming Launch of KHINDIVI, the First and Only FDA-Approved Hydrocortisone Oral Solution for Pediatric Patients
Eton Pharmaceuticals announces FDA approval and upcoming commercial launch of KHINDIVI, an oral hydrocortisone solution for pediatric patients.
Read more
Report
Show more news
People
Sean Brynjelsen
Executive Officer, Director
William Troutman
Executive Officer
Paul Maier
Director
Norbert Riedel
Director
Charles Casamento
Director
Mark Baum
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Deer Park
United States
HQ